Argenx Se (ARGX) Operating Income (2016 - 2026)

Argenx Se (ARGX) posted Operating Income of $394.0 million for Q1 2026, up 7.18% on a QoQ basis from $367.6 million in Q4 2025, and up 183.45% year-over-year from $139.0 million in Q1 2025.

Argenx Se (ARGX) Operating Income (2016 - 2026) Analysis & Trends

Argenx Se's Operating Income history runs 11 years deep, the most recent figure standing at $394.0 million for Q1 2026.

  • Quarterly Operating Income rose 183.45% year-over-year to $394.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 billion (up 521.0% YoY) and the FY2025 annual result came in at $1.1 billion, up 4966.57% from the prior year.
  • Operating Income was $394.0 million for Q1 2026 at Argenx Se, up from $367.6 million in the prior quarter.
  • Across five years, Operating Income topped out at $394.0 million in Q1 2026 and bottomed at -$222.7 million in Q1 2022.
  • A 5-year average of $16.5 million and a median of -$80.6 million in 2023 frame the typical range for Operating Income.
  • Annual changes were most pronounced in 2022 — Operating Income tumbled 3036.48% — and 2025, when it jumped 2340.22%.
  • Argenx Se's Operating Income stood at -$114.4 million in 2022, then dropped by 21.14% to -$138.6 million in 2023, then soared by 174.33% to $103.0 million in 2024, then jumped by 256.76% to $367.6 million in 2025, then grew by 7.18% to $394.0 million in 2026.
  • Business Quant data shows ARGX's Operating Income at $394.0 million in Q1 2026, $367.6 million in Q4 2025, and $346.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -27.75 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -15.76 Mn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 249.90 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 1.14 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 642.90 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - -32.68 Mn
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 394.00 Mn
9 Revolution Medicines 37.37 Bn 37.37 Bn - -445.22 Mn
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn 268.64 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 394.00 Mn
Dec 31, 2025 367.61 Mn
Sep 30, 2025 346.19 Mn
Jun 30, 2025 201.06 Mn
Mar 31, 2025 139.00 Mn
Dec 31, 2024 103.04 Mn
Sep 30, 2024 14.19 Mn
Jun 30, 2024 -45.46 Mn
Mar 31, 2024 -93.42 Mn
Dec 31, 2023 -138.62 Mn
Sep 30, 2023 -80.59 Mn
Jun 30, 2023 -102.09 Mn
Mar 31, 2023 -103.74 Mn
Dec 31, 2022 -114.43 Mn
Sep 30, 2022 -208.64 Mn
Jun 30, 2022 -174.54 Mn
Mar 31, 2022 -222.73 Mn
Dec 31, 2021 -230.91 Mn
Sep 30, 2021 7.11 Mn
Jun 30, 2021 13,000,000.50 Bn